These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19410078)

  • 1. Simvastatin as a novel strategy to alleviate periapical lesions.
    Lin SK; Kok SH; Lee YL; Hou KL; Lin YT; Chen MH; Wang CC; Hong CY
    J Endod; 2009 May; 35(5):657-62. PubMed ID: 19410078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin suppresses osteoblastic expression of Cyr61 and progression of apical periodontitis through enhancement of the transcription factor Forkhead/winged helix box protein O3a.
    Lin LD; Lin SK; Chao YL; Kok SH; Hong CY; Hou KL; Lai EH; Yang H; Lee MS; Wang JS
    J Endod; 2013 May; 39(5):619-25. PubMed ID: 23611379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extract of green tea, epigallocatechin-3-gallate, reduces periapical lesions by inhibiting cysteine-rich 61 expression in osteoblasts.
    Lee YL; Hong CY; Kok SH; Hou KL; Lin YT; Chen MH; Wang CC; Lin SK
    J Endod; 2009 Feb; 35(2):206-11. PubMed ID: 19166774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex class II transactivator inhibits cysteine-rich 61 expression in osteoblastic cells and its implication in the pathogenesis of periapical lesions.
    Lee YL; Lin SK; Hong CY; Wang JS; Yang H; Lai EH; Chen MH; Kok SH
    J Endod; 2010 Jun; 36(6):1021-5. PubMed ID: 20478458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis.
    Kok SH; Hou KL; Hong CY; Wang JS; Liang PC; Chang CC; Hsiao M; Yang H; Lai EH; Lin SK
    Arthritis Rheum; 2011 Apr; 63(4):1010-20. PubMed ID: 20191585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate diminishes cytokine-stimulated Cyr61 expression in human osteoblastic cells: a therapeutic potential for arthritis.
    Wu PH; Lin SK; Lee BS; Kok SH; Wang JH; Hou KL; Yang H; Lai EH; Wang JS; Hong CY
    Rheumatology (Oxford); 2012 Nov; 51(11):1953-65. PubMed ID: 22843790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin alleviates the progression of periapical lesions by modulating autophagy and apoptosis in osteoblasts.
    Lai EH; Hong CY; Kok SH; Hou KL; Chao LH; Lin LD; Chen MH; Wu PH; Lin SK
    J Endod; 2012 Jun; 38(6):757-63. PubMed ID: 22595108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling.
    Kok SH; Lin LD; Hou KL; Hong CY; Chang CC; Hsiao M; Wang JH; Lai EH; Lin SK
    Arthritis Rheum; 2013 Mar; 65(3):639-49. PubMed ID: 23239110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical administration of simvastatin recovers alveolar bone loss in rats.
    Seto H; Ohba H; Tokunaga K; Hama H; Horibe M; Nagata T
    J Periodontal Res; 2008 Jun; 43(3):261-7. PubMed ID: 18447852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
    Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
    Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of Glutaminase in Osteoblasts Promotes Macrophage Recruitment in Periapical Lesions.
    Hou KL; Lin SK; Kok SH; Wang HW; Lai EH; Hong CY; Yang H; Wang JS; Lin LD; Chang JZ
    J Endod; 2017 Apr; 43(4):602-608. PubMed ID: 28190586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
    Haslinger B; Kleemann R; Toet KH; Kooistra T
    Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
    Thunyakitpisal PD; Chaisuparat R
    J Pharmacol Sci; 2004 Apr; 94(4):403-9. PubMed ID: 15107580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats.
    Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N
    Stroke; 2008 Apr; 39(4):1276-85. PubMed ID: 18309148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of simvastatin in nonsteroidal anti-inflammatory drugs-induced small bowel injury.
    Kim EK; Cho JH; Jeong AR; Kim EJ; Park DK; Kwon KA; Chung JW; Kim KO; Kim JH; Kim JH; Kim YJ
    J Physiol Pharmacol; 2017 Feb; 68(1):69-77. PubMed ID: 28456771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling.
    Wei YH; Liao SL; Wang CC; Wang SH; Tang WC; Yang CH
    Mediators Inflamm; 2021; 2021():8888913. PubMed ID: 33542676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin inhibits inflammatory response in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages through the microRNA-22/Cyr61 axis.
    Hu T; Chen B; Zhou S; Mao J
    Int J Clin Exp Pathol; 2018; 11(8):3925-3933. PubMed ID: 31949780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of simvastatin on the progression of alveolar bone loss in experimental periodontitis--an animal study.
    Nassar CA; Battistetti GD; Nahsan FP; Olegário J; Marconato J; Marin CF; Faccioni DM; da Costa KF; Kottwitz LB; Nassar PO
    J Int Acad Periodontol; 2014 Jan; 16(1):2-7. PubMed ID: 24712102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury.
    Li B; Mahmood A; Lu D; Wu H; Xiong Y; Qu C; Chopp M
    Neurosurgery; 2009 Jul; 65(1):179-85; discussion 185-6. PubMed ID: 19574840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.